Laurus Labs Ltd.

LAURUSLABS

Market Cap
₹23,267 Cr.
P/E
123.81

Laurus Labs Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
19.43%
3yr Average
27.33%
5yr Average
20.49%
Net Profit Margin
Latest
12.99%
3yr Average
16.73%
5yr Average
12.66%
ROCE
Latest
24.37%
3yr Average
31.21%
5yr Average
24.83%
Debt to Equity
Latest
0.49
3yr Average
0.52
5yr Average
0.57
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

API Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Approved by Canada
      Source
    • Number of ANDA's Filed in Canada
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Laurus Labs Ltd.
    Divis vs Laurus - SOIC
    Why LaurusLabs bought a significant stake in a cell and gene therapy startup ImmunoACT? - Tar
    Laurus | An Emerging Moat? - SOIC
    View the discussion on ValuePickr
    What’s up with Laurus Labs? - StockEdge
    Approval of First Long Acting Injectable HIV Treatment on Laurus Labs - Dr Midhun
    Some Red Flags For Laurus Labs - Deepak Kapur
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline